Detalles de la búsqueda
1.
Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
Int J Cancer
; 143(3): 496-507, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29473153
2.
Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
Breast Cancer Res
; 18(1): 24, 2016 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26893016
3.
A robust association test for detecting genetic variants with heterogeneous effects.
Biostatistics
; 16(1): 5-16, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25057183
4.
Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.
Breast Cancer Res Treat
; 150(2): 457-466, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773928
5.
Greater absolute risk for all subtypes of breast cancer in the US than Malaysia.
Breast Cancer Res Treat
; 149(1): 285-91, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25537643
6.
Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults.
Cancer Causes Control
; 26(2): 239-246, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25516073
7.
Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression.
Breast Cancer Res Treat
; 143(1): 181-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24292867
8.
Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.
Mol Cancer Res
; 7(2): 199-209, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19208741
9.
Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop Proceedings.
JCO Precis Oncol
; 32019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914013
10.
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy.
Clin Cancer Res
; 24(17): 4066-4071, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29650751
11.
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.
Sci Rep
; 8(1): 6574, 2018 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29700408
12.
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation-Associated Advanced Ovarian Cancer.
Clin Cancer Res
; 23(23): 7165-7170, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28751443
13.
Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy.
Horm Cancer
; 7(5-6): 305-315, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27138982
14.
Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities.
Cancer Prev Res (Phila)
; 9(2): 149-58, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26645278
15.
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
PLoS One
; 11(8): e0160316, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27556229
16.
Health disparities around the world: perspectives from the 2012 Principles and Practice of Cancer Prevention and Control course at the National Cancer Institute.
J Oncol Pract
; 9(6): e284-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24084887
Resultados
1 -
16
de 16
1
Próxima >
>>